1 hr ago
Technical Analysis Favors Mankind Pharma and Engineers India Shares
The article gives buying recommendations for two stocks: Mankind Pharma and Engineers India Ltd.
It sets a price range to aim for and a stop-loss price for each stock.
A stop loss is a price level that can help limit losses if a share falls.
Mankind Pharma’s chart has been moving upward after a recent rebound.
Engineers India’s chart is described as breaking out of a rounded pattern.
The article says trading volume has risen during these upward moves.
It also points to chart indicators that suggest positive momentum.
These are technical assessments, not guarantees that the shares will reach their targets.
The article recommends buying Mankind Pharma, with a target of Rs 2,695–2,760 and a stop loss at Rs 2,365.
Mankind Pharma’s weekly chart is described as forming higher highs and higher lows after rebounding from a 50% retracement.
The article recommends buying Engineers India Ltd, with a target of Rs 335–345 and a stop loss at Rs 275.
Engineers India Ltd is described as breaking out of a rounding-bottom pattern on rising volume.
Both stocks are reported to be above their 20-, 50-, 100- and 200-day simple moving averages, with rising weekly RSI.
- Who
- Mankind Pharma and Engineers India Ltd are the stocks covered.
- What
- The article gives buy recommendations, target prices and stop-loss levels for both stocks.
- Where
- When
- Why
- The recommendations cite chart patterns, rising volume, moving averages and momentum indicators as signs of strength.
Key facts
- Mankind Pharma recommendation
- Buy
- Mankind Pharma target
- Rs 2,695–2,760
- Mankind Pharma stop loss
- Rs 2,365
- Engineers India Ltd recommendation
- Buy
- Engineers India Ltd target
- Rs 335–345
- Engineers India Ltd stop loss
- Rs 275
Sources
Related news
Engineers India Breakout Signals Further Upside, Axis Direct Says
Analysts Recommend BEML, Supreme Petrochem and Venky’s Stocks
SMIFS highlights largecap stocks amid prolonged market weakness
Dr Lal PathLabs Seen Rising Above Key Resistance
Three Stocks Draw Buy Calls With Targets And Stop-Losses
Bagadia Names Four Breakout Stocks Amid Bearish Index Outlook
Mankind Pharma Rewards Captain Smit Machchhar’s Extraordinary Courage
Kotak Upgrades Mankind Pharma as Domestic Business Recovery Emerges
Why Working Capital Matters for Business Cash Flow and Valuation
Kotak Adds ITC, Mankind and Goa Agro to Model Portfolios
